Narayana Hrudayalaya Limited (NSE:NH)
India
· Delayed Price · Currency is INR | Market Cap | 343.66B |
| Revenue (ttm) | 53.84B |
| Net Income (ttm) | 7.84B |
| Shares Out | 203.10M |
| EPS (ttm) | 38.58 |
| PE Ratio | 43.86 |
| Forward PE | 39.91 |
| Dividend | 4.00 (0.24%) |
| Ex-Dividend Date | Aug 2, 2024 |
| Volume | 402,402 |
| Average Volume | 2,493,384 |
| Open | 1,673.55 |
| Previous Close | 1,673.40 |
| Day's Range | 1,659.15 - 1,700.00 |
| 52-Week Range | 1,080.00 - 1,724.35 |
| Beta | 0.46 |
| RSI | 66.80 |
| Earnings Date | May 19, 2025 |
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology se... [Read more]
Financial Performance
In 2023, Narayana Hrudayalaya's revenue was 50.18 billion, an increase of 10.79% compared to the previous year's 45.30 billion. Earnings were 7.89 billion, an increase of 30.19%.
Financial StatementsNews
Narayana Hrudayalaya’s subsidiary HCCI enters joint venture for cancer care in India
Narayana Hrudayalaya Limited (NHL) has announced that its wholly owned overseas subsidiary, Health City Cayman Islands Ltd. (HCCI), has signed a Joint Venture Agreement with 2070 Health Inc., W Health...
Stocks to watch today on 21 Feb: Cipla, Senores, Narayana Hrudayalaya, Sanofi in pharmaceuticals and healthcare sector
The pharmaceuticals and healthcare sector is witnessing significant advancements with new product approvals, strategic acquisitions, and expansions. Key stocks to watch today are: Cipla: Received USFD...
Narayana Hrudayalaya Ltd (NSE:NH) Q3 2025 Earnings Report Preview: What To Look For
Narayana Hrudayalaya Ltd (NSE:NH) Q3 2025 Earnings Report Preview: What To Look For
Key Results Today: Glenmark Pharma, ABFRL, GNFC, and Narayana Hrudayalaya among stocks in focus as Q3 results roll in
Several key mid-cap and small-cap companies are set to announce their Q3 FY25 earnings today, drawing investor attention. While no Nifty 50 companies are reporting results, stocks from pharmaceuticals...
Narayana Hrudayalaya shares surge 3% after lLand acquisition in South Bengaluru
Narayana Hrudayalaya’s stock rose by 3% following the company’s announcement of acquiring approximately 3 acres of land in South Bengaluru. As of 10:58 AM, the shares were trading 3.31% higher at Rs 1...
Narayana Hrudayalaya expands footprint with new land purchase in Bengaluru
Narayana Hrudayalaya, a leading healthcare provider in India, has acquired approximately 3 acres of land in South Bengaluru as part of its business expansion strategy. This move aligns with the compan...
Zaggle Prepaid Ocean Services collaborates with Narayana Hrudayalaya for employee expense management solutions
Zaggle Prepaid Ocean Services Limited, a leading fintech company specializing in innovative payment solutions, has announced a significant partnership with Narayana Hrudayalaya Limited, a reputed heal...
Stocks in focus: Tata Invest, Narayana Hrudayalaya, BF Utilities, Sudarshan Pharma and others set to announce Q2 FY24-25 results today
A series of key financial results for the quarter ending September 2024 are expected today from several companies. Notable among them are Tata Investment Corporation and Narayana Hrudayalaya, whose fi...